Diagnostic reliability of a single IGF‐I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Summary: objective Within an appropriate clinical context, GH deficiency (GHD) in adults must be demonstrated biochemically by a single provocative test. Insulin‐induced hypoglycaemia (ITT) and GH‐releasing hormone (GHRH) + arginine (ARG) are indicated as the tests of choice, provided that appropriate cut‐off limits are defined. Although IGF‐I is the best marker of GH secretory status, its measurement is not considered a reliable diagnostic tool. In fact, considerable overlap between GHD and normal subjects is present, at least when patients with suspected GHD are considered independently of the existence of other anterior pituitary defects. Considering the time and cost associated with provocative testing procedures, we aimed to re‐evaluate the diagnostic power of IGF‐I measurement. design To this goal, in a large population [n = 237, 139 men, 98 women, age range 20–80 years, body mass index (BMI) range 26·4 ± 4·3 kg/m 2] of well‐nourished adults with total anterior pituitary deficit including severe GHD (as shown by a GH peak below the 1st centile limit of normal response to GHRH + ARG tests and/or ITT) we evaluated the diagnostic value of a single total IGF‐I measurement. IGF‐I levels in hypopituitary patients were evaluated based on age‐related normative values in a large population of normal subjects (423 ns, 144 men and 279 women, age range 20–80 years, BMI range 18·2–24·9 kg/m 2). results Mean IGF‐I levels in GHD were lower than those in normal subjects in each decade, but not the oldest one (74·4 ± 48·9 vs. 243·9 ± 86·7 µg/l for 20–30 years; 81·8 ± 46·5 vs. 217·2 ± 56·9 µg/l for 31–40 years; 85·8 ± 42·1 vs. 168·5 ± 69·9 µg/l for 41–50 years; 82·3 ± 39·3 vs. 164·3 ± 60·3 µg/l for 51–60 years; 67·5 ± 31·8 vs. 123·9 ± 50·0 µg/l for 61–70 years; P < 0·0001; 54·3 ± 33·6 vs. 91·6 ± 53·5 µg/l for 71–80 years, P = ns). Individual IGF‐I levels in GHD were below the age‐related 3rd and 25th centile limits in 70·6% and 97·63% of patients below 40 years and in 34·9% and 77·8% of the remaining patients up to the 8th decade, respectively. conclusions Total IGF‐I levels are often normal even in patients with total anterior hypopituitarism but this does not rule out severe GHD that therefore ought to be verified by provocative testing of GH secretion. However, despite the low diagnostic sensitivity of this parameter, very low levels of total IGF‐I can be considered definitive evidence of severe GHD in a remarkable percentage of total anterior hypopituitary patients who could therefore skip provocative testing of GH secretion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
The Diagnosis of Growth Hormone Deficiency in Children and Adults
Shalet, S. M., Toogood, A., Rahim, A., & Brennan, B. M. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0329 · Cited by 414
Diagnosis of growth-hormone deficiency in adults
Hoffman, D. M., O'Sullivan, A. J., Ho, K. K. Y., & Baxter, R. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90181-3 · Cited by 386 · cited 11×
“…hormone (GHRH) + arginine (ARG) are indicated as the tests of choice; in fact, provided that appropriate cut-off limits are defined, it has been shown that both these tests distinguish normal from GHD adults (Hoffman et al., 1994; Ghigo et al., 1996, 1998, 2001; Aimaretti et al., 1998a).”
BackgroundMethodInfluentialAimaretti, G., Corneli, G., Razzore, P., Bellone, S., Baffoni, C., Arvat, E., Camanni, F., & Ghigo, E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4837 · Cited by 272 · cited 15×
“Indeed, the sensitivity of IGF-I was acceptable up to 40 years of age, in agreement with previous studies in patients suspected for GHD both isolated and associated with other pituitary deficits (Toogood et al., 1994; Aimaretti et al., 1998b).”
BackgroundMethodResultInfluentialSelf-citationNew approach to the diagnosis of growth hormone deficiency in adults
Ghigo, E., Aimaretti, G., Gianotti, L., Bellone, J., Arvat, E., & Camanni, F. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1340352 · Cited by 257 · cited 13×
“In fact, mean IGFI levels as well as IGFBP-3 and 24-h GH concentrations in GHD are lower than in normal adults but there is considerable overlap between the two groups (Hoffman et al., 1994; Bates et al., 1995; De Boer et al., 1995; Ghigo et al., 1996; Juul et al., 1997; Svensson et al., 1997; Aimaretti et al., 1998b,…”
BackgroundMethodResultInfluentialSelf-citationGH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults
Popovic, V., Leal, A., Micic, D., Koppeschaar, H. P., Torres, E., Paramo, C., Obradovic, S., Dieguez, C., & Casanueva, F. F. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02755-0 · Cited by 185 · cited 1×
“Very recently, the reliability of the combined test with GHRH and GHRP-6 has been shown in an extensive study (Popovic et al., 2000).”
Background
Cited by
Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study
Aimaretti, G., Ambrosio, M. R., Di Somma, C., Gasperi, M., Cannavò, S., Scaroni, C., Fusco, A., Del Monte, P., De Menis, E., Faustini-Fustini, M., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0504 · Cited by 370
Self-citationAimaretti, G., Ambrosio, M. R., Di Somma, C., Fusco, A., Cannavò, S., Gasperi, M., Scaroni, C., De Marinis, L., Benvenga, S., Uberti, E. C. D., et al. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02094.x · Cited by 339
Self-citationCorneli, G., Di Somma, C., Baldelli, R., Rovere, S., Gasco, V., Croce, C. G., Grottoli, S., Maccario, M., Colao, A., Lombardi, G., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01967 · Cited by 317
Self-citationHypopituitarism induced by traumatic brain injury in the transition phase
Aimaretti, G., Ambrosio, M. R., Di Somma, C., Gasperi, M., Cannavò, S., Scaroni, C., De Marinis, L., Baldelli, R., Bona, G., Giordano, G., et al. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345336 · Cited by 70
Self-citationKasturi, B. S., & Stein, D. G. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0751 · Cited by 57
“However, the reliability of serum IGF-1 as an indicator of GH deficiency is being debated (Aimaretti et al., 1998, 2003; Granada et al., 2000).”
Metadata
- Authors
- Aimaretti, G., Corneli, G., Baldelli, R., Di Somma, C., Gasco, V., Durante, C., Ausiello, L., Rovere, S., Grottoli, S., Tamburrano, G., & Ghigo, E.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2003-06-16
- Volume
- 59
- Issue
- 1
- Pages
- 56-61
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2015040854
- Cited by
- 67
- References
- 6
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnostic reliability of a single IGF‐I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency. https://app.cochat.ai/papers/10.1046/j.1365-2265.2003.01794.x
- The paper
- Aimaretti, G., Corneli, G., Baldelli, R., Di Somma, C., Gasco, V., Durante, C., Ausiello, L., Rovere, S., Grottoli, S., Tamburrano, G., & Ghigo, E. (2003). Diagnostic reliability of a single IGF‐I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2003.01794.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.